GenFlat Holdings, Inc. GFLT

FY2026 · ended Jun 30, 2026 · Revenue $6,120, -22.5% YoY · Filed Sep 25, 2026

GenFlat Holdings, Inc. (GFLT) files with the SEC under industry code 8742, Services-Management Consulting Services. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $6,120 and a net loss of $3.3 million. Free cash flow was -$4.0 million. As of Jun 30, 2026 it held $2.5 million in cash and investments and $22,989 in total debt.

Revenue
$6,120
-22.5% vs prior year
Net income
$-3.28M
+29.8% vs prior year
Operating cash flow
$-3.96M
-235.9% vs prior year
Free cash flow
$-3.96M
-235.9% vs prior year
EPS
$-0.28
+36.4% vs prior year
Dividend per share
None
Shares outstanding
13.11M
+21.5% vs prior year
Net cash
$2.44M
FY 2026
Operating margin
-54135.9%
FY 2026

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
GFLT (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Tooele, UT
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1796949
Former names
Healthcare Business Resources, Inc. (until May 15, 2024)

Other Services-Management Consulting Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Jun 30, 2026
FY 2025
Jun 30, 2025
FY 2024
Jun 30, 2024
FY 2023
Feb 28, 2023
FY 2022
Feb 28, 2022
Revenue
$6,120
$7,894
$5,234
$1,884
$28,942
Operating income
-$3.3M
-$4.7M
-$1.2M
-$170,366
-$1.6M
Net income
-$3.3M
-$4.7M
-$1.2M
-$166,596
-$1.7M
Diluted EPS
-$0.28
-$0.44
—
-$0.01
—
Operating cash flow
-$4.0M
-$1.2M
-$2.4M
-$51,506
-$280,655
Free cash flow
-$4.0M
-$1.2M
-$2.4M
—
—
Total assets
$4.7M
$686,053
$1.8M
$121,060
$165,566
Total liabilities
$245,305
$393,985
$277,338
$179,782
$336,935
Stockholders' equity
$4.5M
$295,468
$1.5M
-$58,722
-$171,369
Cash and investments
$2.5M
$49,830
$38,971
$14,192
$26,013
Total debt
$22,989
$22,989
$8,127
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-K Annual report Sep 25, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 4, 2026 Feb 2, 2026
8-K Current report
Officer or director change
Dec 30, 2025 Dec 30, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.